CarissaChuMD

Surgical Oncology

Assistant Professor

Dr. Chu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Carissa Chu is a San Francisco-based urologist who completed her medical education at the University of California San Francisco School of Medicine in 2014 and a surgical residency there from 2014 to 2015. She has contributed several publications to the field, focusing on various aspects of urothelial carcinoma and its treatment. Her research includes work on molecular heterogeneity, immune infiltration, and specific gene alterations in urothelial carcinoma, with her studies appearing in journals like European Urology and Clinical Cancer Research. She has also explored women's perspectives on sexual function post-radical cystectomy and the use of non-invasive testing in bladder cancer management.

PubMed

Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma.
Kwanghee Kim, Syed M Alam, Fengshen Kuo, Ziyu Chen, Wesley Yip
European Urology. 2025-03-01
1 citations
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.
Xiaolin Zhu, Emily Chan, Michelle L Turski, Carlos Espinosa Mendez, Sarah C Hsu
The Oncologist. 2024-08-05
2 citations
"I think my vagina is still there?": Women's perspectives on sexual function and dysfunction following radical cystectomy for bladder cancer, a qualitative study.
Rachel Carmen Ceasar, Seyedeh-Sanam Ladi-Seyedian, Domenique Escobar, Jullet Han, Kailyn Koh
The Journal of Sexual Medicine. 2024-04-30

Felix Feng, Giant in the Field of Prostate Cancer, Dies at 48January 22nd, 2025
Clinical Challenges: Can MRI and Biomarkers Replace Biopsy for AS in Prostate Cancer?December 2nd, 2020